Company intelligence
Lumanity
We Engineer Breakthrough Value
About Lumanity
We are committed to cracking the code on the future of healthcare by revolutionizing how value is generated, demonstrated, and communicated to unlock the full potential of your brand and your company. Our unique perspectives and agile approach equip you to thrive in an ever-changing healthcare marketplace by accelerating and optimizing access to life-changing medicines.
Verified activity
Signals from Lumanity
11 published signals
Presence & Recognition
Lumanity's Moira Ringo, VP of Market Access Strategy, is speaking to APM Market Access in two feature articles on US drug pricing.
Reported by Lumanity
Products & Services
Lumanity introduced Lumanity Lens, a newsletter covering the full product lifecycle from clinical development through commercialization.
Reported by Lumanity
Presence & Recognition
Lumanity is hosting a CancerProgress webinar on November 10th as a follow-up to the June 2026 BIO panel featuring Adina P., Axel Hoos, Hans-Peter Gerber, and Johanna K. Kaufmann, plus Kaveri Pohlman, PhD, MBA.
Reported by Jeff Bockman
Research & Knowledge
Lumanity published a study on RevMed's franchise and biologic synergy combo studies, looking at daraxonrasib with RevMed's own G12 D, C and V specific agents plus SOC.
Reported by Jeff Bockman
Presence & Recognition
Lumanity is attending the World Conference on Lung Cancer (WCLC) in Seoul next week alongside the International Association for the Study of Lung Cancer (IASLC).
Reported by Dennis Chang
Research & Knowledge
Lumanity's Moira Ringo, VP of Market Access Strategy, spoke with APM Market Access across two feature articles this week on topics including the falling Consumer Price Index, MFN policies, the Inflation Reduction Act, patent cliffs, and biosimilar competition.
Reported by Lumanity
Legal & Regulatory
Lumanity notes that Novartis and Bristol Myers Squibb paused their CD19 CAR-T autoimmune trials.
Reported by Jakub Kaczor, PhD
Presence & Recognition
Lumanity published a podcast episode titled Medical Affairs Unscripted featuring host Peg Crowley-Nowick and Lori Lebson, former SVP of Global Medical Affairs at KalVista Pharmaceuticals, discussing portfolio diversity and strategy challenges.
Reported by Lumanity
People
Lumanity Strategy Consulting is offering an internship program over 10 weeks from mid June through mid August 2027 in a hybrid environment out of Boston, MA or New York, NY offices.
Reported by Jeff Bockman
Presence & Recognition
Lumanity VP of Scientific Strategy, Wilson Joe, PhD, CMPP, will join Hashem A. Dbouk, PhD, CMPP, Director, BioPharma Medical Evidence Publications, Infectious Diseases, AstraZeneca, as plenary faculty at the 2026 International Society for Medical Publication Professionals (ISMPP) Academy.
Reported by Lumanity
Presence & Recognition
Lumanity featured Moira Ringo, VP of Market Access Strategy, in two APM Market Access interviews on the influences affecting the US Consumer Price Index for prescription drug reductions.
Reported by Lumanity